MSCAST- ام اس کست

In this episode we talked about geriatric MS with dr. Iman Adibithank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

Here in the 33rd episode, we continue the 2022 journal highlights with Dr. Adibi thank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

Here in the 32th episode we go through 2022 journal highlights with Dr. Adibi thank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

 in the 31st episode of MS Cast, we talked about Pregnancy and lactation in people diagnosed with MS together with Dr. Adibi thank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

Episode 30a post-congress episodethank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

Episode 29thank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

Episode 28thank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

Episode 27in this episode we talk about breaking through and scalation of MS with Dr. Iman Adibithank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

Episode 26this episode talks about response monitoring tools of MS treatment with Dr. Iman Adibithank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

Episode 25this episode talks about new treatments and new drugs of MS treatment with Dr. Iman Adibithank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

Episode 24this episode talks about the Efficacy of MS treatments with Dr. Iman Adibithank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

Episode 23this episode talks about First line treatment of MS with Dr. Iman Adibithank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

episode 22this episode is a Journal watch to review some article with Dr. Iman AdibiDOI of the first study: DOI of the second study:DOI of the first study:10.3340/jkns.2021.0195http://doi.org/10.3340/jkns.2021.0195DOI of the second study:10.1136/jnnp-2022-329227http://dx.doi.org/10.1136/jnnp-2022-329227DOI of the third study: 10.2217/nmt-2022-0009https://doi.org/10.2217/nmt-2022-000910.1177/13524585221102587:DOI of the fourth study https://doi.org/10.1177%2F13524585221102587DOI of the fifth study: 10.1093/braincomms/fcac181https://doi.org/10.1093/braincomms/fcac181DOI of the sixth study: 10.3390/biomedicines10071629https://doi.org/10.3390/biomedicines10071629DOI of the seventh study: 10.3390/brainsci12070954 https://doi.org/10.3390/brainsci12070954DOI of the eighth study: 10.1016/j.jcrc.2022.153985https://doi.org/10.1016/j.jcrc.2022.153985thank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

In this episode, we are talking about recent topics of MS in EAN 2022 ___thank's Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

episode 20 talks about the Epstein-Barr virus (EBV) and MS relationshipDOI of the study: 10.1212/WNL.0b013e318215286dhttps://doi.org/10.1212/WNL.0b013e318215286d thank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

episode 19this episode talks about Journal watchDOI of the first study: 10.1007/s00415-022-11205-9https://doi.org/10.1007/s00415-022-11205-9DOI of the second study:10.1007/s00415-022-11215-7https://doi.org/10.1007/s00415-022-11215-7DOI of the third study: 10.1016/j.msard.2021.103437https://doi.org/10.1016/j.msard.2021.103437DOI of the fourth study:10.3389/fimmu.2022.834644https://doi.org/10.3389/fimmu.2022.834644DOI of the fifth study: 10.1016/j.msard.2022.103638https://doi.org/10.1016/j.msard.2022.103638DOI of the sixth study: 10.1016/j.msard.2022.103760https://doi.org/10.1016/j.msard.2022.103760thank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

episode 18 talks about treatment optimizationDOI of first study:https://doi.org/10.1007/s00415-020-10074-4DOI of second study:http://dx.doi.org/10.1136/jnnp.2008.145805thank's Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

episode 17This episode talksabout Patient profile & prognostication in Multiple SclerosisDOI of study:10.1016/j.msard.2021.102854https://www.sciencedirect.com/science/article/pii/S2211034821001206Thanks' Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

episode 16This episode talksabout Pregnancy Management in Multiple Sclerosis and Other Demyelinating DiseasesDOI of study:10.1212/CON.0000000000001108https://journals.lww.com/continuum/Abstract/2022/02000/Pregnancy_Management_in_Multiple_Sclerosis_and.4.aspxThanks' Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

episode 15The second episode talksabout Canadian MS Working GroupUpdated Recommendationsand switching medication positionDOI of study:10.1017/S0317167100014244https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/treatment-optimization-in-ms-canadian-ms-working-group-updated-recommendations/F7CA82BA3ADDD05DB9EF45D60802DE01Thanks' Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

episode 14The first episode talksabout Canadian MS Working GroupUpdated Recommendationsand switching medication positionDOI of study:10.1017/S0317167100014244https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/treatment-optimization-in-ms-canadian-ms-working-group-updated-recommendations/F7CA82BA3ADDD05DB9EF45D60802DE01Thanks' Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

episode 13This episode talks about common side effects of ms medicationand necessary tests for screeningThanks' Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

episode 12The last episode talks about Myelitis  AND  Autoimmune  Myelopathy in spinal cord category in continuum Feb 2021DOI of study:10.1007/978_3_030_61883-4_27https://books.google.com/books?hl=en&lr=&id=qTsiEAAAQBAJ&oi=fnd&pg=PA433&dq=Myelitis%2BAutoimmune%2BMyelopathy%2Bspinal+cord%2Bcategory+(continuum)+++2021+&ots=PjTEg13DQM&sig=k0EDBMPko9wyv1favu1Lyofd9Qs#v=onepage&q&f=falseJournal watch:first Article: Self-perceived versus physician documented adverse events in patients with multiple sclerosis REGIMS - a pharmacovigilance registry for patients with multiple sclerosis in GermanyDOI of study:10.1016/j.msard.2022.103684https://www.sciencedirect.com/science/article/pii/S2211034822001997?casa_token=0DubVZHjMksAAAAA:_67S9LFKMd-VMqabUiNu9yykFeMZoIyOTi7Xt12J287ELGxN-opERpEnRbjilauBY-NUK9KfIwsecond Article: Telemedicine during the Coronavirus Disease (COVID-19) Pandemic: A Multiple Sclerosis (MS) Outpatients Service PerspectiveDOI of study:10.3390/neurolint13010003https://www.mdpi.com/2035-8377/13/1/3Third Article: Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patientsDOI of study:10.1186/s12974-021-02339-0https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-021-02339-0Thanks' Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

episode 11The second episode talks about Myelitis  AND  Autoimmune  Myelopathy in spinal cord category in continuum Feb 2021DOI of study:10.1007/978_3_030_61883-4_27https://books.google.com/books?hl=en&lr=&id=qTsiEAAAQBAJ&oi=fnd&pg=PA433&dq=Myelitis%2BAutoimmune%2BMyelopathy%2Bspinal+cord%2Bcategory+(continuum)+++2021+&ots=PjTEg13DQM&sig=k0EDBMPko9wyv1favu1Lyofd9Qs#v=onepage&q&f=falsewith Journal watchhttps://www.nanoalvand.com/

episode 10The first episode talks about Myelitis  AND  Autoimmune  Myelopathy in spinal cord category in continuum Feb 2021 DOI of study:10.1007/978_3_030_61883-4_27https://books.google.com/books?hl=en&lr=&id=qTsiEAAAQBAJ&oi=fnd&pg=PA433&dq=Myelitis%2BAutoimmune%2BMyelopathy%2Bspinal+cord%2Bcategory+(continuum)+++2021+&ots=PjTEg13DQM&sig=k0EDBMPko9wyv1favu1Lyofd9Qs#v=onepage&q&f=falseJournal watch:first Article: Recovery From COVID-19 in Multiple Sclerosis A Prospective and Longitudinal Cohort Study of the United Kingdom Multiple Sclerosis RegisterDOI of study:10.1212/NXI.0000000000001118https://nn.neurology.org/content/9/1/e1118.abstractsecond Article: Impact of Ramadan fasting on disease activity in patients with multiple sclerosis: a multicenter studyDOI of study:10.1080/1028415X.2021.2006955https://www.tandfonline.com/doi/abs/10.1080/1028415X.2021.2006955Third Article: Epigenetic Plasticity Enables CNS-Trafficking of EBV-infected B LymphocytesDOI of study:10.1371/journal.ppat.1009618https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.10096181Thanks' Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

episode 9The last episode talks about global protocol of MRI in MS patients:1)Optic nerve2)Review of the whole study3)Estimation of future of SubjectDOI of study:10.1016/S1474-4422(21)00095-8https://www.sciencedirect.com/science/article/abs/pii/S1474442221000958tJournal watch:first Article: A proinflammatory diet is associated with an increased likelihood of first clinical diagnosis of central nervous system demyelination in womenDOI of study:10.1016/j.msard.2021.103428https://www.sciencedirect.com/science/article/abs/pii/S2211034821006945?casa_token=5T_-6p6QM_kAAAAA:2mHpWvxMNEqyys25_KtJiPDk5tRn3n1t6R_UMw2Fq_o5gjzErM7IgxCnvtDMKo0PS8pIrqdTdAsecond Article: The prevalence of paramagnetic rim lesions in multiple sclerosis: A systematic review and meta-analysisDOI of study:10.1371/journal.pone.0256845https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0256845Third Article: Rituximab Infusion Timing, Cumulative Dose, and Hospitalization for COVID-19 in Persons With Multiple Sclerosis in SwedenDOI of study:10.1001/jamanetworkopen.2021.36697https://jamanetwork.com/journals/jamanetworkopen/article-abstract/2786701Thanks' Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

episode 8talking about Covid-19 Demyelination in journal of neuroimmunologyDOI of  study:10.1016/j.jneuroim.2021.577765https://www.sciencedirect.com/science/article/pii/S0165572821002927thanks' Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

episode 7continue talking about global protocol of MRI in MS patients:1)اگر در ام ار ای کرایتریای تشخیصی را پر نکندبا چه بازه ای باید ام ار ای را تکرار کرد؟2)به غیر از ام ار ای بیس لاین در چه زمان هایی ام ار ای با کنتراست لازم است؟3)با توجه به اینکه گادلنیوم کم عارضه است،این همه حساسیت از کجا می آید؟4)کاربرد ام ار ای در مانیتورینگ بیماری چیه؟5) با توجه به محدودیت روش های اتوماتیک تحلیل تصویر اطلاعات مانیتورینگ یا کشف پلاک جدید یا کلا تغییرات در ام ار ای کمک کننده است؟ 6)پلاک های کورتکس در مانیتورینگ چه نقشی دارند؟7)نکات اسپاینال کورد ام ار ای در مانیتورینگ بیماری چیست؟8)منظور از ام ار ای ری بیس لاین چیست؟ 9)منظور از (safety) چیه و قراره چه مواردی را بررسی کنیم10)در پی ام ال نقش تشخیصی ام ار ای بیش از یافته های سرولوژی است؟11)Pediatric guideline12)pregnant guidelineDOI of study:10.1016/S1474-4422(21)00095-8https://www.sciencedirect.com/science/article/abs/pii/S1474442221000958Thanks' Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

episode 6talking about two article in JAMA neurology on peri-Vaccination and MS DOI of first study:10.1001/jamaneurol.2021.3609https://jamanetwork.com/journals/jamaneurology/fullarticle/2784448DOI of second study:10.1001/jamaneurol.2021.3599https://jamanetwork.com/journals/jamaneurology/article-abstract/2784449thanks' Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

episode 5continue talking about global protocol of MRI in MS patients:1)Central vein sign in new Guideline2)what is post-contrast T1?3)spinal cord diagnostic report of MRI4)در ام ار ای بیس لاین جدا از تشخیص باید جویای چه اطلاعاتی باشیم5) در گاید لاین جدید برای یکسان شدن تفسیر ها هم صحبت خاصی کرده؟6)MRI report template and then talking about Objective medication adherence and persistence in people with multiple sclerosis: a systematic review, meta-analysis, and meta-regressionDOI of first study:10.1016/S1474-4422(21)00095-8https://www.sciencedirect.com/science/article/abs/pii/S1474442221000958DOI of second study:jmcp.2021.27.9.1273https:www.jmcp.org/doi/full/10.18553/jmcp.2021.27.9.1273thank's Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

episode 4talking about Vaccination and MS and then continuing with MS is not associated with an increased risk for severe COVID-19DOI of first study:10.1136/jnnp-2021-326839https://jnnp.bmj.com/content/92/10/1033.shareDOI of second study:10.1186/s42466-021-00143-yhttps://rdcu.be/cz3Okthank's Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

episode 3continue talking about global protocol of MRI in MS paitents:1)توصیه های تشخیصی برای ام اس در استفاده از ام ار ای چیست؟2)setting of spinal cord3)optic nerve setting4)نکات پرکتیکال ام ار ایand then talking about Fatigue and its relationships with cognitive functioning and depression in paediatric multiple sclerosisDOI of first study:10.1016/S1474-4422(21)00095-8https://www.sciencedirect.com/science/article/abs/pii/S1474442221000958DOI of second study:10.1177/1352458511420846https://journals.sagepub.com/doi/abs/10.1177/1352458511420846thank's Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

episode 2talking about concerto and then talking about effects of Tocilizumab Therapy on Circulating B Cells and T Helper Cells in Patients With NMOSDDOI of first study:10.1177/13524585211032803https://journals.sagepub.com/doi/abs/10.1177/13524585211032803DOI of second study:10.3389/fimmu.2021.703931https://www.frontiersin.org/articles/10.3389/fimmu.2021.703931/fullthank's Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

episode 1talking about global protocol of MRI in MS paitents:1)منظور از گلوبال پروتکل در انجام ام ار ای در ام اس چیست؟2)چه تغییری در پرکتیک نرولوژیست ها ایجاد می کند؟3)سه گروه تنظیم کننده این پروتکل چه کسانی هستند؟4)با توجه به نقش ام ار ای در ام اس گلوبال پروتکل چه اهمیتی خواهد داشت؟and then talking about The effect of national disease-modifying therapy subsidy policy on long-term disability outcomes in people with multiple sclerosisDOI of first study:10.1016/S1474-4422(21)00095-8https://www.sciencedirect.com/science/article/abs/pii/S1474442221000958DOI of second study:10.1177/13524585211035948https://journals.sagepub.com/doi/abs/10.1177/13524585211035948thank's Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

ام اس کست چیست؟چرا ام اس؟قرار هست اینجا چی بشنویم؟چه افرادی مخاطب برنامه ی ما هستند؟با تشکر حامی مالی ام اس کست-شرکت دارویی نانوالوندwww.nanoalvand.comما را به همکاران خود معرفی کنیدمنتظر ما باشید.